Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Infection

• Publication date

  2011-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jinf.2011.07.001PMID 21763722
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

  2011cited by this paper
• Application of patient population-derived pharmacokinetic-pharmacodynamic relationships to tigecycline breakpoint determination for staphylococci and streptococci.

  2009cited by this paper
• Efficacy of High Doses of Daptomycin versus Alternative Therapies against Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus

  2009cited by this paper
• Comparison of Tigecycline and Vancomycin for Treatment of Experimental Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus aureus

  2009cited by this paper
• In vitro effect of physiological concentrations of human albumin on the antibacterial activity of tigecycline.

  2009cited by this paper
• Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies.

  2009influential reference
• Efficacy of linezolid alone and in combination with rifampin in staphylococcal experimental foreign-body infection.

  2008cited by this paper
• In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens.

  2008cited by this paper
• Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

  2008cited by this paper
• Limitations of vancomycin in the management of resistant staphylococcal infections.

  2007cited by this paper
• Comparative Activities of Daptomycin, Linezolid, and Tigecycline against Catheter-Related Methicillin-Resistant Staphylococcus Bacteremic Isolates Embedded in Biofilm

  2007cited by this paper
• Tigecycline: a critical analysis.

  2006influential reference
• Efficacy of High Doses of Levofloxacin in Experimental Foreign-Body Infection by Methicillin-Susceptible Staphylococcus aureus

  2006influential reference
• The pharmacokinetic and pharmacodynamic profile of tigecycline.

  2005cited by this paper
• Antibiotics in laboratory medicine

  2005cited by this paper
• Tigecycline: what is it, and where should it be used?

  2005cited by this paper
• Pharmacokinetic/pharmacodynamic profile for tigecycline-a new glycylcycline antimicrobial agent.

  2005cited by this paper
• Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model.

  2005cited by this paper
• Prosthetic-joint infections.

  2004cited by this paper
• Antimicrobial Activity of Tigecycline (GAR‐936) Against Enterococcus faecium and Staphylococcus aureus Used Alone and in Combination

  2002cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard

  2000cited by this paper
• Pharmacokinetics and Pharmacodynamics of Levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in Human Skin Blister Fluid

  2000cited by this paper
• Therapeutic Efficacy of GAR-936, a Novel Glycylcycline, in a Rat Model of Experimental Endocarditis

  2000cited by this paper
• Bacterial biofilms: a common cause of persistent infections.

  1999cited by this paper
• Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

  1998cited by this paper
• Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group.

  1998cited by this paper
• Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus.

  1994cited by this paper
• Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants

  1993cited by this paper
• Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials.

  1991cited by this paper
• Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus

  1990cited by this paper
• Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections

  1985cited by this paper
• Pathogenesis of foreign body infection: description and characteristics of an animal model.

  1982cited by this paper

• Antibacterial effects of BB-Cl-Amidine against multidrug-resistant Gram-positive pathogens via membrane disruption

  2025cites this paper
• The impact of surgical strategy and rifampin on treatment outcome in Cutibacterium periprosthetic joint infections.

  2020cites this paper
• Clinical Experience with Tigecycline in the Treatment of Prosthetic Joint Infections

  2019cites this paper
• Hip and Knee Section, Treatment, Antimicrobials: Proceedings of International Consensus on Orthopedic Infections.

  2019cites this paper
• General Assembly, Treatment, Antimicrobials: Proceedings of International Consensus on Orthopedic Infections.

  2019cites this paper
• Management of Periprosthetic Joint Infection

  2018cites this paper
• Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.

  2018cites this paper
• choice and duration of antibiotic therapy in polymicrobial surgical site infection / periprosthetic joint infection ( SSI / PJI ) ?

  2018cites this paper
• Tigecycline: Alone or in combination?

  2016influential citation
• Propionibacterium acnes: from Commensal to Opportunistic Biofilm-Associated Implant Pathogen

  2014cites this paper
• Experimental study of the efficacy of daptomycin for the treatment of cephalosporin-resistant pneumococcal meningitis.

  2014cites this paper
• Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case–control study

  2013cites this paper
• Short communication: Pheromonicin-SA affects mRNA expression of toll-like receptors, cytokines, and lactoferrin by Staphylococcus aureus-infected bovine mammary epithelial cells.

  2012cites this paper
• Isolation and Characterization of Methicillin Resistant Staphylococcus aureus (MRSA) and Antibacterial Activity of some Plant Extracts Against MRSA

  2012cites this paper
• Efficacy of Daptomycin-Cloxacillin Combination in Experimental Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus

  2012cites this paper
• Fosfomycin-Daptomycin and Other Fosfomycin Combinations as Alternative Therapies in Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus

  2012cites this paper
• Efficacy of Daptomycin-Cloxacillin Combination in Experimental Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus aureus

  2012cites this paper